Endo International PLC (ENDP) Expected to Post Earnings of $0.47 Per Share
Wall Street brokerages expect Endo International PLC (NASDAQ:ENDP) (TSE:ENL) to announce earnings of $0.47 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for Endo International’s earnings, with estimates ranging from $0.40 to $0.52. Endo International reported earnings per share of $0.76 during the same quarter last year, which would suggest a negative year-over-year growth rate of 38.2%. The business is scheduled to issue its next earnings report on Wednesday, August 14th.
On average, analysts expect that Endo International will report full year earnings of $2.17 per share for the current year, with EPS estimates ranging from $2.10 to $2.25. For the next year, analysts anticipate that the company will report earnings of $2.41 per share, with EPS estimates ranging from $1.72 to $3.15. Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for Endo International.
Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its earnings results on Thursday, May 9th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. Endo International had a negative net margin of 18.35% and a negative return on equity of 199.18%. The firm had revenue of $720.00 million during the quarter, compared to the consensus estimate of $692.31 million. During the same quarter in the previous year, the company posted $0.67 EPS. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. LS Investment Advisors LLC acquired a new stake in shares of Endo International during the 4th quarter valued at approximately $59,000. Neuberger Berman Group LLC acquired a new stake in shares of Endo International during the 3rd quarter valued at approximately $202,000. First Quadrant L P CA acquired a new stake in shares of Endo International during the 4th quarter valued at approximately $92,000. Signition LP acquired a new stake in Endo International in the first quarter worth $139,000. Finally, Factorial Partners LLC acquired a new stake in Endo International in the first quarter worth $193,000. 90.95% of the stock is owned by institutional investors.
ENDP stock traded down $0.15 during trading on Friday, hitting $5.97. The stock had a trading volume of 29,817 shares, compared to its average volume of 3,280,272. Endo International has a 1-year low of $5.96 and a 1-year high of $18.50. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of 2.07 and a beta of 1.12.
Endo International Company Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Recommended Story: Understanding Specialty Certificates of Deposit
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.